BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 37686395)

  • 1. Fluorogenic Granzyme A Substrates Enable Real-Time Imaging of Adaptive Immune Cell Activity.
    Cheng Z; Thompson EJ; Mendive-Tapia L; Scott JI; Benson S; Kitamura T; Senan-Salinas A; Samarakoon Y; Roberts EW; Arias MA; Pardo J; Galvez EM; Vendrell M
    Angew Chem Weinheim Bergstr Ger; 2023 Feb; 135(8):e202216142. PubMed ID: 38515764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery and therapeutic potential of human granzyme B.
    Kurschus FC; Jenne DE
    Immunol Rev; 2010 May; 235(1):159-71. PubMed ID: 20536562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granzyme B in skin inflammation and disease.
    Turner CT; Lim D; Granville DJ
    Matrix Biol; 2019 Jan; 75-76():126-140. PubMed ID: 29247692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Genetically Encoded Dark-to-Bright Biosensor for Visualisation of Granzyme-Mediated Cytotoxicity.
    Bednar C; Kübel S; Cordsmeier A; Scholz B; Menschikowski H; Ensser A
    Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding the mechanisms of chimeric antigen receptor (CAR) T cell-mediated killing of tumors: insights from granzyme and Fas inhibition.
    Montalvo MJ; Bandey IN; Rezvan A; Wu KL; Saeedi A; Kulkarni R; Li Y; An X; Sefat KMSR; Varadarajan N
    Cell Death Dis; 2024 Feb; 15(2):109. PubMed ID: 38307835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse cytotoxic T cell-derived granzyme B activates the mitochondrial cell death pathway in a Bim-dependent fashion.
    Catalán E; Jaime-Sánchez P; Aguiló N; Simon MM; Froelich CJ; Pardo J
    J Biol Chem; 2015 Mar; 290(11):6868-77. PubMed ID: 25605735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization of cytolytic T cell differentiation and granule exocytosis with T cells from mice expressing active fluorescent granzyme B.
    Mouchacca P; Schmitt-Verhulst AM; Boyer C
    PLoS One; 2013; 8(6):e67239. PubMed ID: 23840635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differential contribution of granzyme A and granzyme B in cytotoxic T lymphocyte-mediated apoptosis is determined by the quality of target cells.
    Pardo J; Balkow S; Anel A; Simon MM
    Eur J Immunol; 2002 Jul; 32(7):1980-5. PubMed ID: 12115618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time detection of CTL function reveals distinct patterns of caspase activation mediated by Fas versus granzyme B.
    Li J; Figueira SK; Vrazo AC; Binkowski BF; Butler BL; Tabata Y; Filipovich A; Jordan MB; Risma KA
    J Immunol; 2014 Jul; 193(2):519-28. PubMed ID: 24928990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAR T therapy beyond cancer: the evolution of a living drug.
    Baker DJ; Arany Z; Baur JA; Epstein JA; June CH
    Nature; 2023 Jul; 619(7971):707-715. PubMed ID: 37495877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells.
    Bergmann C; Müller F; Distler JHW; Györfi AH; Völkl S; Aigner M; Kretschmann S; Reimann H; Harrer T; Bayerl N; Boeltz S; Wirsching A; Taubmann J; Rösler W; Spriewald B; Wacker J; Atzinger A; Uder M; Kuwert T; Mackensen A; Schett G
    Ann Rheum Dis; 2023 Aug; 82(8):1117-1120. PubMed ID: 37147112
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus.
    Mackensen A; Müller F; Mougiakakos D; Böltz S; Wilhelm A; Aigner M; Völkl S; Simon D; Kleyer A; Munoz L; Kretschmann S; Kharboutli S; Gary R; Reimann H; Rösler W; Uderhardt S; Bang H; Herrmann M; Ekici AB; Buettner C; Habenicht KM; Winkler TH; Krönke G; Schett G
    Nat Med; 2022 Oct; 28(10):2124-2132. PubMed ID: 36109639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains.
    Gordon KS; Kyung T; Perez CR; Holec PV; Ramos A; Zhang AQ; Agarwal Y; Liu Y; Koch CE; Starchenko A; Joughin BA; Lauffenburger DA; Irvine DJ; Hemann MT; Birnbaum ME
    Nat Biomed Eng; 2022 Jul; 6(7):855-866. PubMed ID: 35710755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparameter Longitudinal Imaging of Immune Cell Activity in Chimeric Antigen Receptor T Cell and Checkpoint Blockade Therapies.
    Xie J; El Rami F; Zhou K; Simonetta F; Chen Z; Zheng X; Chen M; Balakrishnan PB; Dai SY; Murty S; Alam IS; Baker J; Negrin RS; Gambhir SS; Rao J
    ACS Cent Sci; 2022 May; 8(5):590-602. PubMed ID: 35647285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies.
    Scott JI; Mendive-Tapia L; Gordon D; Barth ND; Thompson EJ; Cheng Z; Taggart D; Kitamura T; Bravo-Blas A; Roberts EW; Juarez-Jimenez J; Michel J; Piet B; de Vries IJ; Verdoes M; Dawson J; Carragher NO; Connor RAO; Akram AR; Frame M; Serrels A; Vendrell M
    Nat Commun; 2022 May; 13(1):2366. PubMed ID: 35501326
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.